AQP4 variants were directly associated with regional brain volumes, atrophy, and cognition, and were also associated with differences in regional brain volumes, atrophy, and cognitive decline in interaction with sleep duration, latency, and quality.
Key Findings
Results
AQP4 genetic variants were directly associated with regional brain volumes and atrophy in cognitively unimpaired individuals with evidence of amyloid beta accumulation.
Data were drawn from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Participants were cognitively unimpaired individuals with evidence of Aβ accumulation.
Direct associations were found between AQP4 variants and regional brain volumes and atrophy independent of sleep measures.
These associations represent a direct pathway between AQP4 genetic variation and structural AD-related phenotypes.
Results
AQP4 variants were directly associated with cognition in cognitively unimpaired individuals with amyloid beta accumulation.
The study examined cognitively unimpaired individuals, meaning associations were detectable prior to clinical impairment.
Both direct and sleep-moderated relationships between AQP4 variants and cognition were identified.
The cognitive associations add to prior literature linking AQP4 variants to AD diagnosis and cognitive outcomes.
Results
AQP4 variants interacted with sleep duration, latency, and quality to affect regional brain volumes and atrophy.
Sleep measures used were self-reported and included sleep duration, latency, and quality.
The interaction between AQP4 variants and sleep measures was associated with differences in regional brain volumes and atrophy.
These findings suggest AQP4 variants may modulate the relationship between sleep and structural brain changes relevant to AD.
Prior work had suggested AQP4 may affect the sleep and amyloid beta relationship, and these findings extend that work to structural brain phenotypes.
Results
AQP4 variants were associated with cognitive decline in interaction with sleep disturbances.
Sleep disturbances interacted with AQP4 variants to predict cognitive decline trajectories.
This represents a sleep-moderated pathway by which AQP4 genetic variation relates to AD-related cognitive phenotypes.
The findings support the hypothesis that AQP4 influences AD progression both directly and through its interaction with sleep.
Conclusions
The study supports both direct and sleep-moderated relationships between AQP4 variants and Alzheimer's disease phenotypes.
AQP4 variants have previously been associated with AD diagnosis, cognition, and brain amyloid beta.
This study extends prior findings to include regional brain volumes, atrophy, and cognitive decline as additional phenotypes.
Both direct associations and interactions with multiple sleep parameters (duration, latency, quality, disturbances) were identified.
The study population was restricted to cognitively unimpaired individuals with Aβ accumulation, situating findings in early disease stages.
What This Means
This research examined how genetic variants in a gene called AQP4 — which produces a water channel protein in brain cells thought to help clear waste from the brain during sleep — relate to early signs of Alzheimer's disease. Using data from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study, the researchers focused on people who had no thinking or memory problems yet but did show early signs of amyloid buildup in their brains, a hallmark of Alzheimer's disease. They found that certain AQP4 gene variants were linked to differences in brain structure (size of specific brain regions and rates of brain shrinkage) and cognitive performance even without considering sleep.
The study also found that the relationship between AQP4 variants and brain structure and cognition was influenced by sleep. Specifically, people with certain AQP4 variants showed different patterns of brain volume changes and cognitive decline depending on how long they slept, how long it took them to fall asleep, and the quality and disturbances of their sleep. This suggests that AQP4 doesn't just have a direct effect on brain health — it also interacts with sleep patterns to shape Alzheimer's-related changes in the brain.
This research suggests that the AQP4 gene may play a role in Alzheimer's disease risk and progression through two pathways: one that operates independently of sleep and one that works through sleep. Because AQP4 is involved in the brain's waste-clearance system, which is most active during sleep, these findings point to the importance of understanding how genetics and sleep together influence brain health. This could have implications for identifying people at higher risk for Alzheimer's disease and for exploring whether sleep interventions might be more beneficial for certain genetic groups.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Porter T, Armstrong A, O'Brien E, Doré V, Bourgeat P, Turner M, et al.. (2026). Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypes.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71516